On CNBC’s “Halftime Report Final Trades,” Bryn Talkington of Requisite Capital Management said AbbVie Inc. ABBV has a 4.5% yield and high free cash flow yield.
AbbVie reported reimbursement for VRAYLAR for the treatment of schizophrenia under Non-Insured Health Benefits (NIHB) Program.
Stephen Weiss of Short Hills Capital Partners said Deere & Company DE may go back to over $400 level.
BMO Capital analyst John Joyner, last week, maintained Deere with a Market Perform and lowered the price target from $450 to $425.
Don’t forget to check out our premarket coverage here
Joseph Terranova of Virtus Investment Partners said Broadcom Inc. AVGO is going to be a winner in AI.
Shares of Broadcom gained on Monday on reports suggesting EU Antitrust Regulators are set to approve Broadcom’s acquisition of VMware.
Price Action: Broadcom shares rose 6.4% to settle at $855.36, while Deere shares rose 2.2% to close at $387.13 on Monday. AbbVie shares fell 0.3% to close at $137.73 during the Monday’s session.
Check This Out: Top 5 Industrials Stocks That May Rocket Higher This Month
Photo: Shutterstock
